Literature DB >> 31774307

Doxorubicin-induced oxidative stress differentially regulates proteolytic signaling in cardiac and skeletal muscle.

Ryan N Montalvo1, Vivian Doerr1, Kisuk Min1, Hazel H Szeto2, Ashley J Smuder1.   

Abstract

Doxorubicin (DOX) is a highly effective antineoplastic agent used in cancer treatment. Unfortunately, clinical use of DOX is limited due to the development of dose-dependent toxicity to cardiac and respiratory (i.e., diaphragm) muscles. After administration, DOX preferentially localizes to the inner mitochondrial membrane, where it promotes cellular toxicity via enhanced mitochondrial reactive oxygen species (ROS) production. Although recent evidence suggests that amelioration of mitochondrial ROS emission preserves cardiorespiratory muscle function following DOX treatment, the mechanisms responsible for this protection remain unknown. Therefore, we tested the hypothesis that DOX-induced mitochondrial ROS production is required to stimulate pathological signaling by the autophagy/lysosomal system (ALS), the ubiquitin-proteasome pathway (UPP), and the unfolded protein response (UPR). Cause and effect were determined by administration of the mitochondria-targeted peptide SS-31 to DOX-treated animals. Interestingly, while SS-31 abrogated aberrant ROS emission in cardiorespiratory muscles of DOX-treated animals, our results revealed muscle-specific regulation of effector pathways. In the heart, SS-31 prevented DOX-induced proteolytic signaling through the ALS and UPP. In contrast, ALS signaling was inhibited by SS-31 in the diaphragm, but the UPP was not affected. UPR signaling was activated in both muscles at eukaryotic translation initiation factor 2α (eIF2α) S51 in the heart and diaphragm of DOX-treated animals and was attenuated with SS-31 treatment in both tissues. However, downstream signaling of eIF2α (activating transcription factor 4 and CCAAT/enhancer-binding protein homologous protein) was diminished in the heart but upregulated in the diaphragm with DOX. Collectively, these results show that DOX-induced ROS production plays distinct roles in the regulation of cardiac and diaphragm muscle proteolysis.

Entities:  

Keywords:  SS-31; adriamycin; autophagy; heart; respiratory; ubiquitin-proteasome

Mesh:

Substances:

Year:  2019        PMID: 31774307     DOI: 10.1152/ajpregu.00299.2019

Source DB:  PubMed          Journal:  Am J Physiol Regul Integr Comp Physiol        ISSN: 0363-6119            Impact factor:   3.619


  16 in total

Review 1.  Bone-Muscle Crosstalk: Musculoskeletal Complications of Chemotherapy.

Authors:  Brian A Hain; David L Waning
Journal:  Curr Osteoporos Rep       Date:  2022-09-10       Impact factor: 5.163

2.  SS-31 does not prevent or reduce muscle atrophy 7 days after a 65 kdyne contusion spinal cord injury in young male mice.

Authors:  Zachary A Graham; Jennifer J DeBerry; Christopher P Cardozo; Marcas M Bamman
Journal:  Physiol Rep       Date:  2022-05

Review 3.  The Impact of Immune Cells on the Skeletal Muscle Microenvironment During Cancer Cachexia.

Authors:  Brandon N VanderVeen; E Angela Murphy; James A Carson
Journal:  Front Physiol       Date:  2020-08-31       Impact factor: 4.566

Review 4.  Understanding the common mechanisms of heart and skeletal muscle wasting in cancer cachexia.

Authors:  Valentina Rausch; Valentina Sala; Fabio Penna; Paolo Ettore Porporato; Alessandra Ghigo
Journal:  Oncogenesis       Date:  2021-01-08       Impact factor: 7.485

Review 5.  Consideration of Sex as a Biological Variable in the Development of Doxorubicin Myotoxicity and the Efficacy of Exercise as a Therapeutic Intervention.

Authors:  Ryan N Montalvo; Vivian Doerr; Branden L Nguyen; Rachel C Kelley; Ashley J Smuder
Journal:  Antioxidants (Basel)       Date:  2021-02-25

Review 6.  Mitochondrial Dysfunction Is a Common Denominator Linking Skeletal Muscle Wasting Due to Disease, Aging, and Prolonged Inactivity.

Authors:  Hayden W Hyatt; Scott K Powers
Journal:  Antioxidants (Basel)       Date:  2021-04-11

7.  Hyperthermia Enhances Doxorubicin Therapeutic Efficacy against A375 and MNT-1 Melanoma Cells.

Authors:  Diana Salvador; Verónica Bastos; Helena Oliveira
Journal:  Int J Mol Sci       Date:  2021-12-21       Impact factor: 5.923

Review 8.  Mechanisms of exercise-induced preconditioning in skeletal muscles.

Authors:  Scott K Powers; Matthew Bomkamp; Mustafa Ozdemir; Hayden Hyatt
Journal:  Redox Biol       Date:  2020-02-20       Impact factor: 11.799

9.  Protection against Doxorubicin-Induced Cardiac Dysfunction Is Not Maintained Following Prolonged Autophagy Inhibition.

Authors:  Ryan N Montalvo; Vivian Doerr; Oh Sung Kwon; Erin E Talbert; Jeung-Ki Yoo; Moon-Hyon Hwang; Branden L Nguyen; Demetra D Christou; Andreas N Kavazis; Ashley J Smuder
Journal:  Int J Mol Sci       Date:  2020-10-30       Impact factor: 5.923

10.  Prevention of Doxorubicin-Induced Autophagy Attenuates Oxidative Stress and Skeletal Muscle Dysfunction.

Authors:  Vivian Doerr; Ryan N Montalvo; Oh Sung Kwon; Erin E Talbert; Brian A Hain; Fraser E Houston; Ashley J Smuder
Journal:  Antioxidants (Basel)       Date:  2020-03-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.